JP2004528809A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004528809A5 JP2004528809A5 JP2002532629A JP2002532629A JP2004528809A5 JP 2004528809 A5 JP2004528809 A5 JP 2004528809A5 JP 2002532629 A JP2002532629 A JP 2002532629A JP 2002532629 A JP2002532629 A JP 2002532629A JP 2004528809 A5 JP2004528809 A5 JP 2004528809A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid sequence
- sequence seq
- consensus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical group 0.000 description 10
- 101001130247 Homo sapiens Reticulon-4 receptor-like 2 Proteins 0.000 description 4
- 101001130249 Mus musculus Reticulon-4 receptor-like 1 Proteins 0.000 description 4
- 102000053414 human RTN4RL2 Human genes 0.000 description 4
- 102000000343 Nogo Receptor 1 Human genes 0.000 description 2
- 108010041199 Nogo Receptor 1 Proteins 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 101001130250 Homo sapiens Reticulon-4 receptor-like 1 Proteins 0.000 description 1
- 102000010410 Nogo Proteins Human genes 0.000 description 1
- 108010077641 Nogo Proteins Proteins 0.000 description 1
- 101710095853 Reticulon-4 receptor-like 1 Proteins 0.000 description 1
- 102100031540 Reticulon-4 receptor-like 1 Human genes 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23836100P | 2000-10-06 | 2000-10-06 | |
| PCT/US2001/031488 WO2002029059A2 (en) | 2000-10-06 | 2001-10-06 | Nogo receptor homologs |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009022063A Division JP2009100767A (ja) | 2000-10-06 | 2009-02-02 | Ｎｏｇｏレセプターホモログ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004528809A JP2004528809A (ja) | 2004-09-24 |
| JP2004528809A5 true JP2004528809A5 (enExample) | 2005-03-03 |
| JP4465148B2 JP4465148B2 (ja) | 2010-05-19 |
Family
ID=22897532
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002532629A Expired - Fee Related JP4465148B2 (ja) | 2000-10-06 | 2001-10-06 | Ｎｏｇｏレセプターホモログ |
| JP2009022063A Withdrawn JP2009100767A (ja) | 2000-10-06 | 2009-02-02 | Ｎｏｇｏレセプターホモログ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009022063A Withdrawn JP2009100767A (ja) | 2000-10-06 | 2009-02-02 | Ｎｏｇｏレセプターホモログ |
Country Status (12)
| Country | Link |
|---|---|
| US (5) | US20030124704A1 (enExample) |
| EP (1) | EP1325130B1 (enExample) |
| JP (2) | JP4465148B2 (enExample) |
| AT (1) | ATE458815T1 (enExample) |
| AU (2) | AU2002211539B2 (enExample) |
| CA (1) | CA2424834A1 (enExample) |
| DE (1) | DE60141409D1 (enExample) |
| DK (1) | DK1325130T3 (enExample) |
| ES (1) | ES2341608T3 (enExample) |
| NZ (1) | NZ525422A (enExample) |
| PT (1) | PT1325130E (enExample) |
| WO (1) | WO2002029059A2 (enExample) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7119165B2 (en) | 2000-01-12 | 2006-10-10 | Yale University | Nogo receptor-mediated blockade of axonal growth |
| ATE458815T1 (de) * | 2000-10-06 | 2010-03-15 | Univ Yale | Homologe des nogo rezeptors |
| JP2005507246A (ja) * | 2001-08-27 | 2005-03-17 | ノバルティス アクチエンゲゼルシャフト | Ｎｏｇｏレセプターホモログおよびそれらの使用 |
| WO2003035687A1 (en) * | 2001-10-22 | 2003-05-01 | Novartis Ag | Nogo receptor homologues and their use |
| US7309485B2 (en) * | 2001-12-03 | 2007-12-18 | Children's Medical Center Corporation | Reducing myelin-mediated inhibition of axon regeneration |
| AU2003246254A1 (en) * | 2002-07-05 | 2004-01-23 | Shionogi And Co., Ltd. | NOVEL Nogo RECEPTOR-LIKE POLYPEPTIDE AND DNA THEREOF |
| DK1534736T3 (da) | 2002-08-10 | 2010-09-20 | Biogen Idec Inc | Nogo-receptorantagonister |
| PL2248899T3 (pl) | 2003-03-19 | 2015-10-30 | Biogen Ma Inc | Białko wiążące receptor nogo |
| CA2521469A1 (en) | 2003-04-04 | 2004-10-21 | University Of Rochester | Identification of novel nogo-receptors and methods related thereto |
| CA2522649A1 (en) * | 2003-04-16 | 2004-11-04 | Biogen Idec Ma Inc. | Treatment of conditions involving amyloid plaques |
| EA008253B1 (ru) * | 2003-08-07 | 2007-04-27 | Байоджен Айдек Ма Инк. | Антагонисты nogo-рецептора |
| US8912144B2 (en) * | 2003-12-16 | 2014-12-16 | Children's Medical Center Corporation | Method for treating stroke via administration of NEP1-40 and inosine |
| EP1695061A4 (en) * | 2003-12-16 | 2008-02-20 | Childrens Medical Center | METHOD OF TREATING NEUROLOGICAL DISORDERS |
| WO2005074972A2 (en) * | 2004-01-30 | 2005-08-18 | Biogen Idec Ma Inc. | Treatment of conditions involving dopaminergic neuronal degeneration using nogo receptor antagonists |
| DK1776136T3 (da) | 2004-06-24 | 2012-12-03 | Biogen Idec Inc | Behandling af tilstande, der involverer demyelinisering |
| CN101035803A (zh) * | 2004-10-01 | 2007-09-12 | 耶鲁大学 | Nogo－a多肽片段、变异nogo受体－1多肽、及其应用 |
| US7893032B2 (en) | 2005-07-07 | 2011-02-22 | Yale University | NgR variants and compositions thereof for suppressing axonal growth inhibition |
| CA2902070A1 (en) | 2005-07-08 | 2007-01-18 | Biogen Idec Ma Inc. | Sp35 antibodies and uses thereof |
| EP1940446A4 (en) * | 2005-08-25 | 2009-08-05 | Biogen Idec Inc | NOGO RECEPTOR POLYPEPTIDE POLYPEPTIDES AND FRAGMENTS AND USES THEREOF |
| CN103215293B (zh) | 2006-01-27 | 2015-10-28 | 比奥根Ma公司 | Nogo受体拮抗剂 |
| WO2007133746A2 (en) * | 2006-05-15 | 2007-11-22 | Biogen Idec Ma Inc. | Use of nogo receptor-1 (ngr1) antagonists for promoting oligodendrocyte survival |
| EP2037945A4 (en) * | 2006-05-24 | 2012-07-04 | Myelin Repair Foundation Inc | PERMEABILITY OF THE HEMATO-ENCEPHALIC BARRIER |
| ES2437110T3 (es) | 2006-11-14 | 2014-01-08 | Genentech, Inc. | Moduladores de la regeneración neuronal |
| US20100047232A1 (en) * | 2006-11-14 | 2010-02-25 | Jasvinder Atwal | Modulators of neuronal regeneration |
| WO2009009743A2 (en) * | 2007-07-12 | 2009-01-15 | Institute For Advance Study | Sequence optimization for expression of a foreign gene |
| AU2008335245A1 (en) * | 2007-12-11 | 2009-06-18 | Genentech, Inc. | Modulators of neuronal regeneration |
| EP2276500A4 (en) | 2008-03-13 | 2015-03-04 | Univ Yale | REACTIVATION OF AXON GROWTH AND AXON RECOVERY IN CHRONIC REVERSE MARKET INJURIES |
| US20090285803A1 (en) * | 2008-05-13 | 2009-11-19 | Jasvinder Atwal | ANTI-PirB ANTIBODIES |
| US8058406B2 (en) | 2008-07-09 | 2011-11-15 | Biogen Idec Ma Inc. | Composition comprising antibodies to LINGO or fragments thereof |
| EP2392208B1 (en) * | 2010-06-07 | 2016-05-04 | Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Fusion proteins comprising a DNA-binding domain of a Tal effector protein and a non-specific cleavage domain of a restriction nuclease and their use |
| US9120111B2 (en) | 2012-02-24 | 2015-09-01 | Rain Bird Corporation | Arc adjustable rotary sprinkler having full-circle operation and automatic matched precipitation |
| US9796780B2 (en) | 2012-05-14 | 2017-10-24 | Biogen Ma Inc. | LINGO-2 antagonists for treatment of conditions involving motor neurons |
| US9156043B2 (en) | 2012-07-13 | 2015-10-13 | Rain Bird Corporation | Arc adjustable rotary sprinkler with automatic matched precipitation |
| EP3242893A1 (en) | 2015-01-08 | 2017-11-15 | Biogen MA Inc. | Lingo-1 antagonists and uses for treatment of demyelinating disorders |
| US12343748B2 (en) | 2021-03-16 | 2025-07-01 | Rain Bird Corporation | Multi-mode rotor sprinkler apparatus and method |
| US12434252B2 (en) | 2022-04-20 | 2025-10-07 | Rain Bird Corporation | Full-circle and part-circle rotor sprinkler |
| US12440855B2 (en) | 2022-10-27 | 2025-10-14 | Rain Bird Corporation | Multi-mode rotor sprinkler apparatus and method |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1341050C (en) | 1988-11-04 | 2000-07-11 | Martin E. Schwab | Neurite growth regulatory factors |
| AU652537B2 (en) | 1988-11-04 | 1994-09-01 | Erziehungsdirektion Of The Canton Zurich | Neurite growth regulatory factors |
| US5250414A (en) | 1988-11-04 | 1993-10-05 | Erziehungsdirektion Of The Canton Zurich | Diagnostic methods using neurite growth regulatory factors |
| JPH07509002A (ja) | 1993-02-11 | 1995-10-05 | エルツィーヒュングスディレクション オブ ザ キャントン チューリッヒ | ニューロトロフィンとミエリン−関連の軸索成長阻害タンパク質に対する抗体との組み合わせが中枢神経系の再生を促進する |
| WO2000073452A2 (en) | 1999-06-02 | 2000-12-07 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| US5858708A (en) * | 1996-08-12 | 1999-01-12 | Bandman; Olga | Polynucleotides encoding two novel human neuroendocrine-specific proteins |
| WO2000070050A1 (en) | 1999-05-14 | 2000-11-23 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| JP2003521216A (ja) * | 1997-08-05 | 2003-07-15 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | ９０個のヒト分泌タンパク質 |
| ES2312205T3 (es) | 1998-03-10 | 2009-02-16 | Genentech, Inc. | Nuevo polipeptido y acidos nucleicos que lo codifican. |
| JP2002518010A (ja) | 1998-06-16 | 2002-06-25 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | ９４個のヒト分泌タンパク質 |
| PT1098972E (pt) | 1998-07-22 | 2010-12-14 | Smithkline Beecham Ltd | Proteína semelhante a proteína especificamente neuroendócrina e adnc codificante |
| KR100728405B1 (ko) * | 1998-11-06 | 2007-06-13 | 더 유니버시티 오브 취리히 | Ｎｏｇｏ 유전자의 뉴클레오티드와 단백질 서열 및 이들에기초한 방법 |
| ATE458050T1 (de) | 1998-12-01 | 2010-03-15 | Genentech Inc | Promotion oder inhibition von angiogenese und kardiovaskularisation |
| PT1484338E (pt) | 1998-12-22 | 2007-05-31 | Genentech Inc | Métodos e composições para inibição do crescimento de células neoplásicas. |
| AU3514400A (en) | 1999-03-08 | 2000-09-28 | Genentech Inc. | Compositions and methods for the treatment of immune related diseases |
| JP2004513602A (ja) | 1999-03-08 | 2004-05-13 | ジェネンテック・インコーポレーテッド | 分泌及び膜貫通ポリペプチドとそれをコードしている核酸 |
| JP2004507202A (ja) | 1999-03-31 | 2004-03-11 | キュラジェン コーポレイション | ポリペプチドをコードするオープンリーディングフレームを含む核酸；「ｏｒｆｘ」 |
| AU6394400A (en) | 1999-07-30 | 2001-02-19 | Millennium Pharmaceuticals, Inc. | Secreted proteins and uses thereof |
| WO2001042286A2 (en) * | 1999-12-08 | 2001-06-14 | Millennium Pharmaceuticals, Inc. | Human leucine rich repeat-containing polypeptide and uses therefor |
| US7119165B2 (en) * | 2000-01-12 | 2006-10-10 | Yale University | Nogo receptor-mediated blockade of axonal growth |
| CN100354307C (zh) * | 2000-01-12 | 2007-12-12 | 耶鲁大学 | Nogo受体介导的对轴突生长的阻断 |
| US6436703B1 (en) * | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
| CA2376873A1 (en) | 2000-04-18 | 2001-10-25 | Teijin Limited | Oxygen concentrating apparatus |
| ATE458815T1 (de) * | 2000-10-06 | 2010-03-15 | Univ Yale | Homologe des nogo rezeptors |
| JP2005507246A (ja) | 2001-08-27 | 2005-03-17 | ノバルティス アクチエンゲゼルシャフト | Ｎｏｇｏレセプターホモログおよびそれらの使用 |
| WO2003035687A1 (en) | 2001-10-22 | 2003-05-01 | Novartis Ag | Nogo receptor homologues and their use |
| DK1534736T3 (da) * | 2002-08-10 | 2010-09-20 | Biogen Idec Inc | Nogo-receptorantagonister |
-
2001
- 2001-10-06 AT AT01979595T patent/ATE458815T1/de active
- 2001-10-06 PT PT01979595T patent/PT1325130E/pt unknown
- 2001-10-06 JP JP2002532629A patent/JP4465148B2/ja not_active Expired - Fee Related
- 2001-10-06 ES ES01979595T patent/ES2341608T3/es not_active Expired - Lifetime
- 2001-10-06 AU AU2002211539A patent/AU2002211539B2/en not_active Ceased
- 2001-10-06 EP EP01979595A patent/EP1325130B1/en not_active Expired - Lifetime
- 2001-10-06 US US09/972,546 patent/US20030124704A1/en not_active Abandoned
- 2001-10-06 NZ NZ525422A patent/NZ525422A/en unknown
- 2001-10-06 DE DE60141409T patent/DE60141409D1/de not_active Expired - Lifetime
- 2001-10-06 WO PCT/US2001/031488 patent/WO2002029059A2/en not_active Ceased
- 2001-10-06 DK DK01979595.4T patent/DK1325130T3/da active
- 2001-10-06 CA CA002424834A patent/CA2424834A1/en not_active Abandoned
- 2001-10-06 AU AU1153902A patent/AU1153902A/xx active Pending
-
2003
- 2003-12-12 US US10/735,256 patent/US7173118B2/en not_active Expired - Lifetime
-
2006
- 2006-10-06 US US11/544,013 patent/US7456255B2/en not_active Expired - Lifetime
-
2008
- 2008-11-24 US US12/277,187 patent/US20090175850A1/en not_active Abandoned
-
2009
- 2009-02-02 JP JP2009022063A patent/JP2009100767A/ja not_active Withdrawn
-
2010
- 2010-11-23 US US12/952,747 patent/US20110129477A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004528809A5 (enExample) | ||
| JP2004511201A5 (enExample) | ||
| JP2001520886A5 (enExample) | ||
| JP2001524320A5 (enExample) | ||
| JP2003533986A5 (enExample) | ||
| WO2000022430A3 (en) | Neisseria genomic sequences and methods of their use | |
| BR0010361A (pt) | Seq ências genÈmicas de neisseria e uso destas | |
| CN108779465A (zh) | 用于减少pd-l1表达的寡核苷酸 | |
| MX339406B (es) | Antigenos de neisseria meningitidis y composiciones que los contienen. | |
| EP1246114A3 (en) | Methods for genomic analysis | |
| JP2003192699A5 (enExample) | ||
| CA2143678A1 (en) | Compositions and methods for treatment of hepatitis c virus-associated diseases | |
| DE69829115D1 (de) | Zusammensetzungen und verfahren zur behandlung von hepatitis c virus-bedingten erkrankungen | |
| CA2378148A1 (en) | Nematicidal trifluorobutenes | |
| CA2520541A1 (en) | Antisense oligonucleotides (odn) against smad7 and uses thereof in medical field | |
| JP2001512666A5 (enExample) | ||
| JP2003525623A5 (enExample) | ||
| JP2004501211A5 (enExample) | ||
| JP2009505964A5 (enExample) | ||
| JP2008528624A5 (enExample) | ||
| Schalm | Clinical implications of lamivudine resistance by HBV. | |
| JP2004526737A5 (enExample) | ||
| SE9702002D0 (sv) | Novel compounds | |
| ITTO20000674A0 (it) | Composizioni a base di aminoacidi, atte al trattamento dell'insufficienza cardiaca. | |
| Foreman et al. | Geographically distinct HHV-8 DNA sequences in Saudi Arabian iatrogenic Kaposi's sarcoma lesions |